Radiotherapy of germinomas involving the basal ganglia and thalamus.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1470698.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nine patients with histologically confirmed germinomas of the basal ganglia and thalamus (GBT) were treated by radiotherapy. The average dose of 52.5 Gy was delivered to the tumor bed, 37 Gy to the whole brain and 24.8 Gy to the CNS axis. The local control, which was verified by CT scan, was achieved in all patients. All patients are alive 11 to 96 months after radiotherapy. As with other intracranial germinomas, geminomas of the basal ganglia and thalamus respond well to radiotherapy and the prognosis is good after treatment.
Medical subject headings
- Basal Ganglia
- Brain Neoplasms
- Dysgerminoma
- Thalamus